These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1726549)

  • 1. Mechanisms regulating glycosylation of human acute phase proteins.
    Mackiewicz A; Mackiewicz SH; Pawłowski T
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):365-73. PubMed ID: 1726549
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the acid glycoprotein heterogeneity in patients with arthritis].
    Domysławska I; Lewandowski B; Kita K; Klimiuk PA; Sierakowski S
    Pol Merkur Lekarski; 2004 Oct; 17(100):349-52. PubMed ID: 15690699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activities of some lysosomal enzymes of human white blood cells in rheumatoid arthritis, lupus erythematosus and ankylosing spondylitis].
    Fidelski R; Tchórzewski H; Niedworok J
    Acta Haematol Pol; 1971; 2(3):229-34. PubMed ID: 5161837
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there more than one signal for an acute phase response?
    Richter MB; Coughlan RJ; Panayi GS; Gordon Y
    J Rheumatol; 1985 Dec; 12(6):1048-52. PubMed ID: 2419556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary activity of the blood in rheumatism and certain allied disorders.
    KELLETT CE
    Ann Rheum Dis; 1954 Sep; 13(3):211-8. PubMed ID: 13198055
    [No Abstract]   [Full Text] [Related]  

  • 7. Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.
    Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Gruszewska E; Szmitkowski M; Sierakowski S
    Rheumatol Int; 2014 Mar; 34(3):393-9. PubMed ID: 24346772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of blood viscosity in rheumatic diseases].
    Roques CF; Amigues H; Fournie A; Simon J; Guiraud R
    Nouv Presse Med; 1977 Sep; 6(30):2686. PubMed ID: 409995
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte sedimentation rate within rheumatic disease clinics.
    Giacomello A; Quaratino CP; Zoppini A
    J Rheumatol; 1997 Nov; 24(11):2263-5. PubMed ID: 9375897
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M; Bootsma H; Van Der Geld Y; Limburg PC; Kallenberg CG; Van Rijswijk MH
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major microheterogeneity of alpha 1-acid glycoprotein in management of patients with rheumatic diseases.
    Mackiewicz A; Pawłowski T
    Prog Clin Biol Res; 1989; 300():219-22. PubMed ID: 2789388
    [No Abstract]   [Full Text] [Related]  

  • 12. [N-glycosylation of proteins in rheumatic diseases].
    Hrycaj P; Müller W
    Z Rheumatol; 1992; 51(2):51-4. PubMed ID: 1377440
    [No Abstract]   [Full Text] [Related]  

  • 13. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.
    Watson M; Rudd PM; Bland M; Dwek RA; Axford JS
    Arthritis Rheum; 1999 Aug; 42(8):1682-90. PubMed ID: 10446868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory investigations in connective tissue disease.
    Solomon L
    Mod Trends Orthop; 1972; 5():172-95. PubMed ID: 4114353
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
    Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
    J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-biological research on the necrotizing activity of the blood of patients with collogenosis. II. Research on the nature of the necrotizing factor of the blood of patients with collagen diseases].
    Georgescu C; Chirulescu Z; Ciobanu V
    Stud Cercet Med Interna; 1969; 10(1):47-52. PubMed ID: 4186495
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory cytokines controlling branching of N-heteroglycans of acute phase protein.
    Gryska K; Słupianek A; Laciak M; Górny A; Mackiewicz K; Baumann H; Mackiewicz A
    Adv Exp Med Biol; 1995; 376():239-45. PubMed ID: 8597254
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration and microheterogeneity of acute-phase glycoproteins in patients with systemic lupus erythematosus.
    Domysławska I; Kita K; Sulik A; Lewandowski B; Chwiećko J; Kowal-Bielecka O; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():259-62. PubMed ID: 16119681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum copper in rheumatoid arthritis and ankylosing spondylitis.
    Mäkisara P; Ruutsalo HM; Nissilä M; Ruotsi A; Mäkisara GL
    Ann Med Exp Biol Fenn; 1968; 46(2):177-8. PubMed ID: 5733961
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma proteins glycosylation and its alteration in disease.
    Matei L
    Rom J Intern Med; 1997; 35(1-4):3-11. PubMed ID: 9562647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.